Copyright
©The Author(s) 2025.
World J Clin Cases. Aug 6, 2025; 13(22): 106925
Published online Aug 6, 2025. doi: 10.12998/wjcc.v13.i22.106925
Published online Aug 6, 2025. doi: 10.12998/wjcc.v13.i22.106925
Table 4 Key questions for future research
Research question | Potential impact |
How does P-ADA correlate with disease severity? | Improves prognostic stratification |
Can P-ADA differentiate between specific etiologies (e.g., TB vs cancer)? | Enhances more targeted and effective treatment plans |
What is the role of ADA in resolving inflammation? | Identifies new therapeutic targets for inflammatory conditions |
How does P-ADA interact with other biomarkers (e.g., IL-6, ADA1)? | Strengthens multimodal diagnostics |
Are there genetic variations affecting P-ADA levels? | Explains population-specific differences in cutoffs |
- Citation: Shi DD, Tian J, Ding J. Adenosine deaminase in pleural effusion: Bridging diagnosis and the pathophysiology of inflammation. World J Clin Cases 2025; 13(22): 106925
- URL: https://www.wjgnet.com/2307-8960/full/v13/i22/106925.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v13.i22.106925